Literature DB >> 16271821

Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.

James P Herman1, Michelle M Ostrander, Nancy K Mueller, Helmer Figueiredo.   

Abstract

Limbic dysfunction and hypothalamo-pituitary-adrenocortical (HPA) axis dysregulation are key features of affective disorders. The following review summarizes our current understanding of the relationship between limbic structures and control of ACTH and glucocorticoid release, focusing on the hippocampus, medial prefrontal cortex and amygdala. In general, the hippocampus and anterior cingulate/prelimbic cortex inhibit stress-induced HPA activation, whereas the amygdala and perhaps the infralimbic cortex may enhance glucocorticoid secretion. Several characteristics of limbic-HPA interaction are notable: first, in all cases, the role of given limbic structures is both region- and stimulus-specific. Second, limbic sites have minimal direct projections to HPA effector neurons of the paraventricular nucleus (PVN); hippocampal, cortical and amygdalar efferents apparently relay with neurons in the bed nucleus of the stria terminalis, hypothalamus and brainstem to access corticotropin releasing hormone neurons. Third, hippocampal, cortical and amygdalar projection pathways show extensive overlap in regions such as the bed nucleus of the stria terminalis, hypothalamus and perhaps brainstem, implying that limbic information may be integrated at subcortical relay sites prior to accessing the PVN. Fourth, these limbic sites also show divergent projections, with the various structures having distinct subcortical targets. Finally, all regions express both glucocorticoid and mineralocorticoid receptors, allowing for glucocorticoid modulation of limbic signaling patterns. Overall, the influence of the limbic system on the HPA axis is likely the end result of the overall patterning of responses to given stimuli and glucocorticoids, with the magnitude of the secretory response determined with respect to the relative contributions of the various structures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271821     DOI: 10.1016/j.pnpbp.2005.08.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  380 in total

1.  Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity.

Authors:  Lindsey Ossewaarde; Guido A van Wingen; Mark Rijpkema; Torbjörn Bäckström; Erno J Hermans; Guillén Fernández
Journal:  Hum Brain Mapp       Date:  2011-12-08       Impact factor: 5.038

2.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 3.  Genetic approaches for understanding the role of serotonin receptors in mood and behavior.

Authors:  Zoe R Donaldson; Katherine M Nautiyal; Susanne E Ahmari; René Hen
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

4.  Exogenous testosterone enhances cortisol and affective responses to social-evaluative stress in dominant men.

Authors:  Erik L Knight; Colton B Christian; Pablo J Morales; William T Harbaugh; Ulrich Mayr; Pranjal H Mehta
Journal:  Psychoneuroendocrinology       Date:  2017-08-18       Impact factor: 4.905

5.  Restoration of neuroendocrine stress response by glucocorticoid receptor or GABA(A) receptor antagonists after experimental traumatic brain injury.

Authors:  Anna N Taylor; Delia L Tio; Richard L Sutton
Journal:  J Neurotrauma       Date:  2013-06-27       Impact factor: 5.269

6.  Exercise-associated changes in the corticosterone response to acute restraint stress: evidence for increased adrenal sensitivity and reduced corticosterone response duration.

Authors:  Brendan D Hare; Jacob A Beierle; Donna J Toufexis; Sayamwong E Hammack; William A Falls
Journal:  Neuropsychopharmacology       Date:  2013-11-26       Impact factor: 7.853

7.  A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder.

Authors:  Yiheng Tu; Jiliang Fang; Jin Cao; Zengjian Wang; Joel Park; Kristen Jorgenson; Courtney Lang; Jun Liu; Guolei Zhang; Yanping Zhao; Bing Zhu; Peijing Rong; Jian Kong
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

Review 8.  Stress reactivity after traumatic brain injury: implications for comorbid post-traumatic stress disorder.

Authors:  Ann N Hoffman; Anna N Taylor
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

Review 9.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

10.  Association between changes in heart rate variability during the anticipation of a stressful situation and the stress-induced cortisol response.

Authors:  Matias M Pulopulos; Marie-Anne Vanderhasselt; Rudi De Raedt
Journal:  Psychoneuroendocrinology       Date:  2018-05-03       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.